多发性骨髓瘤
来那度胺
癌症研究
医学
不确定意义的单克隆抗体病
内科学
免疫学
单克隆
抗体
单克隆抗体
出处
期刊:Blood
[Elsevier BV]
日期:2023-01-26
卷期号:141 (4): 328-330
被引量:3
标识
DOI:10.1182/blood.2022018471
摘要
oxygen-carrying capacity.As the number of approved therapies increases, combination therapies may allow hemoglobin levels closer to the lower limits of normal.This work also suggests that current concepts regarding the acceptability of moderate anemia (hemoglobin levels <10 g/dL) need to be reconsidered in the context of cerebral oxygen delivery and brain damage.
科研通智能强力驱动
Strongly Powered by AbleSci AI